Anti-snoring Treatment Market Analysis

Anti-snoring Treatment Market Analysis

Anti-snoring treatment market from continuous positive airway pressure (CPAP) devices is expected to record over 7.5% CAGR through 2023-2032. The growing demand for CPAP devices can be attributed to the increasing use in the treatment of snoring, and obstructive sleep apnea (OSA). CPAP therapy is very effective in keeping the user’s airway open thus ensuring a continuous stream of air with the help of a mask. OSA is one of the most common sleep-related disorders, affecting a large portion of the global population.
 

Anti-snoring treatment market valuation from the E-Commerce Distribution Channel is estimated to reach USD 925 million by 2032. The growing customer inclination toward over-the-counter (OTC) products due to availability, and affordability will propel the demand for anti-snoring devices across online channels. The rise in the number of e-pharmacies and online drug stores is enhancing patient access to treatments that do not require a prescription.
 

E-commerce also offers easy access and favorable pricing to buyers in middle-income countries. Furthermore, extensive developments in the field of internet infrastructure and robust cyber connectivity across rural areas are fueling the use of e-commerce channels for sourcing medical products, including anti-snoring treatments.
 

North America anti-snoring treatment market size is poised to surpass USD 1 billion by 2032. North America is home to a massive healthcare sector with hefty private and public investments, supportive government initiatives, increasing spending, and growing awareness regarding sleep disorders. The grant aims to boost education and awareness associated with OSA in the U.S. Similar private-public initiatives and funding will complement the expansion of the anti-snoring treatment industry in North America.